Approval · Notice of Compliance 1111 · 2000
MARINOL: Notice of Compliance 1111
Issued April 25, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1111
- Date
- April 25, 2000
- Company
- Unimed Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of weight loss associated with wasting syndrome
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MARINOL | Not yet assigned | — |
Medicinal ingredients
- DRONABINOL 2.5 MG per CAP
- DRONABINOL 5 MG per CAP
- DRONABINOL 10 MG per CAP